Clopidogrel & Aspirin Tablets USP
Clopidogrel & Aspirin USP Tablets combine dual antiplatelet action to prevent blood clots, reduce stroke and heart attack risk, and support long-term cardiovascular protection in high-risk patients.
Brand Name: CLOPIDOGREL-A
Generic Name: Clopidogrel & Aspirin Tablets USP
Available Strengths:
75mg+150mg
Clopidogrel & Aspirin USP Tablets provide a powerful dual antiplatelet therapy designed to prevent platelet aggregation and reduce the risk of serious cardiovascular events. This combination is widely prescribed for patients with recent heart attack, stroke, or established arterial disease. Clopidogrel enhances platelet inhibition while Aspirin prevents clot formation, offering comprehensive protection for long-term cardiac health. Manufactured under stringent USP standards, these tablets ensure high purity, consistent efficacy, and reliable performance for global healthcare providers seeking trusted cardiovascular treatment options.
Capabilities Offered:
Ready dossier for both strengths in CTD/ ACTD format
Third party manufacturing services
Contract Manufacturing (CMO Services)
Formulation Development Services
Regulatory & Documentation Support
Export / Licensing Services
In addition to the products listed on our website, we possess the technical capability and infrastructure to develop and manufacture customized formulations as per your specific requirements and regulatory markets.
For business inquiries, email at sales@cooperpharma.com